Literature DB >> 26267660

Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.

Diana Bittersohl1, Birthe Stemplewitz1, Matthias Keserü1, Carsten Buhmann2, Gisbert Richard1, Andrea Hassenstein1.   

Abstract

PURPOSE: The study was performed to analyse the retina of patients with Parkinson's disease (PD) for morphological changes compared to healthy controls (HC) using spectral-domain optical coherence tomography (SD-OCT) and confocal scanning laser ophthalmoscopy.
METHODS: We enrolled 108 patients with idiopathic PD and 165 HC. All study participants underwent an ophthalmological examination to exclude ophthalmological disorder potentially interfering with the retinal analyses. Peripapillary retinal nerve fibre layer (RNFL) thickness and macular thickness and volume were measured by a SD-OCT device (Heidelberg Spectralis(®) ). Stereometric parameters of the optic disc were acquired by Heidelberg Retina Tomograph (HRT III).
RESULTS: The RNFL thickness did not significantly differ between patients with PD and HC. The thickness of the central minimum and the centre of the macular area were significantly reduced in patients with PD, while the total macular volume did not significantly differ between the groups. Furthermore, we noted an inverse correlation between the central minimum thickness and the disease severity (assessed by the Hoehn and Yahr scale). HRT data showed no significant differences.
CONCLUSION: The HRT device and the RNFL measurements of the SD-OCT did not prove to be a clinically valid diagnostic tool to distinguish eyes of patients with PD and HC. However, the macular region and especially the foveola (central minimum) with the highest density of photoreceptor cells seem to be more sensitive and might be potential biomarkers.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Heidelberg retina tomography; Parkinson's disease; Spectral-domain optical coherence tomography; retinal nerve fibre layer

Mesh:

Year:  2015        PMID: 26267660     DOI: 10.1111/aos.12757

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  10 in total

Review 1.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

2.  Do you have restless leg syndrome? I understood from your eyes.

Authors:  Hatice Kose Ozlece; Volkan Solmaz; Sadık Altan Özal; Yahya Çelik
Journal:  Sleep Breath       Date:  2018-10-19       Impact factor: 2.816

Review 3.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

4.  Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.

Authors:  V Polo; M Satue; M J Rodrigo; S Otin; R Alarcia; M P Bambo; M I Fuertes; J M Larrosa; L E Pablo; E Garcia-Martin
Journal:  BMJ Open       Date:  2016-05-06       Impact factor: 2.692

Review 5.  Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases.

Authors:  Maria Satue; Javier Obis; Maria J Rodrigo; Sofia Otin; Maria I Fuertes; Elisa Vilades; Hector Gracia; Jose R Ara; Raquel Alarcia; Vicente Polo; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin
Journal:  J Ophthalmol       Date:  2016-10-20       Impact factor: 1.909

6.  Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry.

Authors:  Birthe Stemplewitz; Robert Kromer; Eik Vettorazzi; Ute Hidding; Andreas Frings; Carsten Buhmann
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

7.  Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.

Authors:  William Seiple; Danna Jennings; Richard B Rosen; Leona Borchert; Lee Canale; Nora Fagan; Mark Forrest Gordon
Journal:  Parkinsons Dis       Date:  2016-12-18

8.  Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases.

Authors:  Ane Murueta-Goyena; Rocío Del Pino; Paula Reyero; Marta Galdós; Begoña Arana; Olaia Lucas-Jiménez; Marian Acera; Beatriz Tijero; Naroa Ibarretxe-Bilbao; Natalia Ojeda; Javier Peña; Jesús Cortés; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Mov Disord       Date:  2019-05-28       Impact factor: 10.338

9.  Association of inner retinal reflectivity with qualitative and quantitative changes in retinal layers over time in diabetic eyes without retinopathy.

Authors:  Ebru N Cetin; Osman Parca; Hasan Samed Akkaya; Gökhan Pekel
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

10.  Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography.

Authors:  Robert Kromer; Carsten Buhmann; Ute Hidding; Matthias Keserü; Diana Keserü; Andrea Hassenstein; Birthe Stemplewitz
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.